VP, FP&A
uniQure
Fabien is a Boston-based global finance executive with 20+ years of experience across private and public companies in the biotech and life sciences sector. He currently serves as VP, Head of FP&A at uniQure, a gene therapy biotech, with prior executive finance leadership experience at Shire, Alexion, and Enzyvant across France, the UK, Switzerland, and the US, bringing deep expertise in financial planning and strategy for rare disease and biotech organizations. Fabien has built his career navigating the financial complexities of clinical-to-commercial stage biotechs. Fluent in French and English, with good knowledge of German, he has worked across global markets including the US, EU, CEE, MENA, Asia, and LATAM. Beyond his executive role, Fabien is active in patient advocacy, supporting families affected by rare diseases through his involvement with nonprofit organizations. He is known for combining rigorous financial leadership with a strong sense of purpose and community engagement.